Notice under section 708A(5) of the Corporations Act
|
30 June 2023 at 7:40pm
|
Application for quotation of securities - BBX
|
30 June 2023 at 7:35pm
|
Results of Meeting
|
29 June 2023 at 6:05pm
|
Impressive Results from Bioleaching Pilot Plant Test
|
27 June 2023 at 10:10am
|
Notification of cessation of securities - BBX
|
22 June 2023 at 6:05pm
|
Bioleaching pilot plant test yields significant results
|
21 June 2023 at 9:25am
|
BBX Broadens REE Focused Exploration Footprint
|
13 June 2023 at 10:25am
|
Identification of 14 new high potential targets at Ema
|
6 June 2023 at 10:25am
|
Notice of General Meeting/Proxy Form
|
29 May 2023 at 6:05pm
|
Significant REE levels at Ema and new tenements applications
|
22 May 2023 at 10:25am
|
Pause in Trading
|
22 May 2023 at 10:25am
|
Notice under section 708A(5) of the Corporations Act
|
10 May 2023 at 5:55pm
|
Application for quotation of securities - BBX
|
10 May 2023 at 5:45pm
|
Commencement of follow up testing and optimisation
|
8 May 2023 at 9:55am
|
Beginning of Environmental Study for Tres Estados Project
|
4 May 2023 at 11:30am
|
Quarterly Activities/Appendix 5B Cash Flow Report
|
28 April 2023 at 11:35am
|
Details of Company Address
|
18 April 2023 at 4:50pm
|
Notice under section 708A(5)(e) of the Corporations Act
|
6 April 2023 at 7:20pm
|
Application for quotation of securities - BBX
|
6 April 2023 at 7:10pm
|
Proposed issue of securities - BBX
|
31 March 2023 at 8:45am
|
BBX Secures Investment of $3 Million
|
31 March 2023 at 8:35am
|
Half Year Interim Financial Report
|
16 March 2023 at 5:15pm
|
Corporate Presentation - PDAC
|
6 March 2023 at 1:35pm
|
Bioleaching - Next Steps
|
6 March 2023 at 10:05am
|
Excellent results from initial pilot plant testing
|
27 February 2023 at 10:30am
|
Initial Director's Interest Notice
|
9 February 2023 at 7:05pm
|
Key Board Appointment to Advance Development Strategy
|
6 February 2023 at 10:50am
|
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 January 2023 at 1:10pm
|
Updated MRE at Tres Estados - 725,230 5E PGM Ounces
|
25 January 2023 at 10:10am
|
Convertible Loan Facility Extended
|
11 January 2023 at 4:40pm
|
Change in substantial holding
|
9 January 2023 at 5:15pm
|
Change of Director's Interest Notice - AD
|
4 January 2023 at 8:45am
|
Notice under section 708A(5)(e) of the Corporations Act
|
29 December 2022 at 2:20pm
|
Application for quotation of securities - BBX
|
29 December 2022 at 2:00pm
|
Change of Director's Interest Notice - KP
|
28 December 2022 at 12:35pm
|
Bioleaching test work continues to show excellent results
|
19 December 2022 at 9:50am
|
Assay Results - EMD-004 to 012
|
16 December 2022 at 4:55pm
|
Change of Director's Interest Notice X3
|
5 December 2022 at 5:15pm
|
Notification regarding unquoted securities - BBX
|
29 November 2022 at 5:45pm
|
Amended Constitution
|
23 November 2022 at 7:35pm
|
Results of Meeting
|
23 November 2022 at 7:15pm
|
Appointment of Chairman
|
23 November 2022 at 8:40am
|
Initial Assay Results - Ema Project
|
17 November 2022 at 3:50pm
|
Initial results from bioleaching test work
|
14 November 2022 at 10:20am
|
Corporate Presentation - November 2022
|
2 November 2022 at 12:40pm
|
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 October 2022 at 9:45am
|
Maiden Mineral Resource at Tres Estados
|
25 October 2022 at 10:05am
|
Trading Halt
|
24 October 2022 at 11:50am
|
Pause in Trading
|
24 October 2022 at 10:30am
|
Notice of Annual General Meeting/Proxy Form
|
21 October 2022 at 5:35pm
|